scPharmaceuticals Inc
NASDAQ:SCPH 4:00:00 PM EDT
| Market Cap (Intraday) | 162.24M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.62 |
| 50-Day MA | $5.28 |
| 200-Day MA | $6.17 |
scPharmaceuticals Inc Stock, NASDAQ:SCPH
25 Burlington Mall Road, Suite 203, Burlington, Massachusetts 01830
United States of America
Phone: +1.617.517.0730
Number of Employees: 136
Description
scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure and scCeftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.